Metabolic profiles by \(^1}\)H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: PLoS one, 12, 4, S. e0176415-1-e0176415-13
- Event
-
Veröffentlichung
- (where)
-
Bochum
- (who)
-
Ruhr-Universität Bochum
- (when)
-
2017
- Creator
-
Schneider, Ruth
Bellenberg, Barbara
Hoepner, Robert
Kolb, Eva-Maria
Ellrichmann, Gisa
Haghikia, Aiden
Gold, Ralf
Lukas, Carsten
- URN
-
urn:nbn:de:hbz:294-58929
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schneider, Ruth
- Bellenberg, Barbara
- Hoepner, Robert
- Kolb, Eva-Maria
- Ellrichmann, Gisa
- Haghikia, Aiden
- Gold, Ralf
- Lukas, Carsten
- Ruhr-Universität Bochum
Time of origin
- 2017
Other Objects (12)
Course of neuropsychological impairment during natalizumab-associated progressive multifocal leukoencephalopathy
Insight into metabolic 1H-MRS changes in natalizumab induced progressive multifocal leukoencephalopathy brain lesions
Krankheitsverlauf und klinisches Outcome von 15 Patienten mit Natalizumabassoziierter progressiver multifokaler Leukenzephalopathie (PML)
Multiple Sklerose - zwischen Grundlagenforschung und klinischer Anwendung
Three cases of non-carryover fingolimod-PML
Natalizumab-associated progressive multifocal leukoencephalopathy (PML) in multiple sclerosis (MS): “a case report from Ireland with review of literature, clinical pitfalls and future direction”
Concomitant granule cell neuronopathy in patients with natalizumab-associated PML
A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes
Natalizumab-treated patients at high risk for PML persistently excrete JC polyomavirus
High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study
Prädiktoren für den Schweregrad und das funktionelle Outcome bei Patienten mit Natalizumab-assoziierter Progressiver multifokaler Leukenzephalopathie
Disease activity and neonatal outcomes after exposure to natalizumab throughout pregnancy
Course of neuropsychological impairment during natalizumab-associated progressive multifocal leukoencephalopathy
Insight into metabolic 1H-MRS changes in natalizumab induced progressive multifocal leukoencephalopathy brain lesions
Krankheitsverlauf und klinisches Outcome von 15 Patienten mit Natalizumabassoziierter progressiver multifokaler Leukenzephalopathie (PML)
Multiple Sklerose - zwischen Grundlagenforschung und klinischer Anwendung
Three cases of non-carryover fingolimod-PML
Natalizumab-associated progressive multifocal leukoencephalopathy (PML) in multiple sclerosis (MS): “a case report from Ireland with review of literature, clinical pitfalls and future direction”
Concomitant granule cell neuronopathy in patients with natalizumab-associated PML
A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes
Natalizumab-treated patients at high risk for PML persistently excrete JC polyomavirus
High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study
Prädiktoren für den Schweregrad und das funktionelle Outcome bei Patienten mit Natalizumab-assoziierter Progressiver multifokaler Leukenzephalopathie
Disease activity and neonatal outcomes after exposure to natalizumab throughout pregnancy
Course of neuropsychological impairment during natalizumab-associated progressive multifocal leukoencephalopathy
Insight into metabolic 1H-MRS changes in natalizumab induced progressive multifocal leukoencephalopathy brain lesions
Krankheitsverlauf und klinisches Outcome von 15 Patienten mit Natalizumabassoziierter progressiver multifokaler Leukenzephalopathie (PML)
Multiple Sklerose - zwischen Grundlagenforschung und klinischer Anwendung
Three cases of non-carryover fingolimod-PML
Natalizumab-associated progressive multifocal leukoencephalopathy (PML) in multiple sclerosis (MS): “a case report from Ireland with review of literature, clinical pitfalls and future direction”
Concomitant granule cell neuronopathy in patients with natalizumab-associated PML
A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes
Natalizumab-treated patients at high risk for PML persistently excrete JC polyomavirus
High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study
Prädiktoren für den Schweregrad und das funktionelle Outcome bei Patienten mit Natalizumab-assoziierter Progressiver multifokaler Leukenzephalopathie